CLINIQUE CICERONE AS

7011 TRONDHEIM

Finances

Return on Equity

72,59 %

Current Ratio

2,43

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	4 238 000	3 747 000	3 212 000	3 363 000
Net Income	1 488 000	1 047 000	773 000	698 000
Total Assets	3 358 000	4 884 000	3 522 000	2 769 000
Total Equity	2 050 000	952 000	2 905 000	2 132 000

Income (NOK)	2022	2021	2020	2019
Revenue	4 238 000	3 747 000	3 212 000	3 363 000
Expenditure	2 495 000	2 410 000	2 240 000	2 448 000
Operating Profit	1 743 000	1 337 000	972 000	915 000
Financial Income	5 000	4 000	8 000	13 000
Financial Costs	0	0	0	0
Financial Balance	5 000	4 000	8 000	13 000
Earnings Before Tax	1 748 000	1 341 000	979 000	927 000
Tax	275 000	294 000	206 000	202 000
Net Income	1 488 000	1 047 000	773 000	698 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	181 000	242 000	307 000	35 000
Total Current Assets	3 177 000	4 642 000	3 215 000	2 734 000
Total Assets	3 358 000	4 884 000	3 522 000	2 769 000
Total Retained Equity	1 889 000	791 000	2 744 000	1 971 000
Total Equity	2 050 000	952 000	2 905 000	2 132 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	1 308 000	3 932 000	616 000	637 000
Total Equity and Debt	3 358 000	4 884 000	3 522 000	2 769 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	4 238 000	3 747 000	3 212 000	3 363 000
Other Income	0	0	0	0
Revenue	4 238 000	3 747 000	3 212 000	3 363 000
Cost of Goods Sold	682 000	550 000	466 000	751 000
Salary Costs	1 350 000	1 463 000	1 296 000	1 241 000
Depreciation	75 000	67 000	65 000	6 000
Impairment	0	0	0	0
Expenditure	2 495 000	2 410 000	2 240 000	2 448 000
Operating Profit	1 743 000	1 337 000	972 000	915 000
Financial Income	5 000	4 000	8 000	13 000
Financial Costs	0	0	0	0
Financial Balance	5 000	4 000	8 000	13 000
Dividends	175 000	300 000	0	350 000
Net Income	1 488 000	1 047 000	773 000	698 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	23 000	8 000	6 000	5 000
Real Eastate	0	11 000	15 000	5 000
Machinery and Plant Facilities	133 000	197 000	261 000	0
Fixtures	25 000	25 000	0	0
Total Tangible Assets	158 000	234 000	301 000	30 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	181 000	242 000	307 000	35 000
Stock	220 000	214 000	221 000	203 000
Total Investments	0	0	0	0
Cash, Bank	2 944 000	4 339 000	2 980 000	2 335 000
Total Current Assets	3 177 000	4 642 000	3 215 000	2 734 000
Total Assets	3 358 000	4 884 000	3 522 000	2 769 000
Total Equity	2 050 000	952 000	2 905 000	2 132 000
Short-Term Group Debt	275 000	2 700 000	8 000	12 000
Total Long-Term Debt	0	0	0	0
Creditors	68 000	88 000	45 000	113 000
Unpaid Taxes	194 000	230 000	161 000	93 000
Dividends	175 000	300 000	0	350 000
Other Current Debt	516 000	590 000	188 000	204 000
Total Current Debt	1 308 000	3 932 000	616 000	637 000
Total Equity and Debt	3 358 000	4 884 000	3 522 000	2 769 000

Financial indicators	2022	2021	2020	2019
Return on Equity	72,59 %	109,98 %	26,61 %	32,74 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	41,13 %	35,68 %	30,26 %	27,21 %
Current Ratio	2,43	1,18	5,22	4,29
Quick Ratio	2,92	1,25	8,14	6,3
Equity Ratio	0,61	0,19	0,82	0,77
Gross Profit Margin	83,91 %	85,32 %	85,49 %	77,67 %